Idebenone Approval Status
FDA Approved: No
Generic name: idebenone
Company: Santhera Pharmaceuticals
Treatment for: Duchenne Muscular Dystrophy
Idebenone is a synthetic short-chain benzoquinone and a substrate for the enzyme NAD(P)H:quinone oxidoreductase (NQO1) in development for the treatment of Duchenne Muscular Dystrophy.
Development Status and FDA Approval Process for idebenone
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.